HSR24-154: Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy—An Analysis of the ADOReg German Skin Cancer Registry

作者：Ruixuan Jiang, Michael Weichenthal, César I. Fernández-Lázaro, Anja Rudolph, Clemens Krepler, Peter Mohr, _ _ · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2024 · DOI：10.6004/jnccn.2023.7273 · 研究领域：Cancer Immunotherapy and Biomarkers、Melanoma and MAPK Pathways、Cutaneous Melanoma Detection and Management

"HSR24-154: Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy—An Analysis of the ADOReg German Skin Cancer Registry" published on 05 Apr 2024 by National Comprehensive Cancer Network.